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The Protein Network of HIV Budding
of other pathogenic human viruses including Ebola andUta K. von Schwedler,1 Melissa Stuchell,1
Barbara Mu¨ller,3 Diane M. Ward,2 HTLV-I (Freed, 2002; Pornillos et al., 2002c). PTAP late
domains recruit the cellular protein TSG101 to facilitateHyo-Young Chung,1 Eiji Morita,1
Hubert E. Wang,4 Thaylon Davis,4 virus budding (Demirov et al., 2002a; Garrus et al., 2001;
Martin-Serrano et al., 2001; VerPlank et al., 2001). InGong-Ping He,4 Daniel M. Cimbora,4
Anna Scott,1 Hans-Georg Kra¨usslich,3 uninfected cells, TSG101 functions in the biogenesis of
the multivesicular body (MVB) (Katzmann et al., 2002),Jerry Kaplan,2 Scott G. Morham,4
and Wesley I. Sundquist1,* which suggests that HIV may bind TSG101 in order to
gain access to the downstream machinery that cata-1Department of Biochemistry
2 Department of Pathology lyzes MVB vesicle budding. Consistent with this model,
a dominant-negative Vps4A protein that inhibits MVBUniversity of Utah
Salt Lake City, Utah 84132 biogenesis also blocks release of HIV-1 and other enve-
loped viruses (Garrus et al., 2001; Licata et al., 2003;3 Abteilung Virologie
Universita¨tsklinikum Heidelberg Martin-Serrano et al., 2003). The mammalian MVB path-
way is not yet fully defined, however. Hence, it is unclearD-69120 Heidelberg
Germany whether other proteins in the MVB pathway participate
in HIV-1 budding.4 Myriad Pharmaceuticals, Inc.
Salt Lake City, Utah 84108 Genetic screens in yeast have defined 17 different
proteins that appear to play direct roles in MVB biogene-
sis (reviewed in Katzmann et al., 2002). All are required
for vacuolar protein sorting (VPS), and are termed “classSummary
E” proteins because their deletion or inactivation in-
duces formation of abnormally enlarged, highly tubu-HIV release requires TSG101, a cellular factor that
sorts proteins into vesicles that bud into multivesicular lated endosomal membrane compartments that fail to
mature normally into MVBs (termed “class E compart-bodies (MVB). To test whether other proteins involved
in MVB biogenesis (the class E proteins) also partici- ments”). Recent studies by Emr and coworkers have
revealed that most class E proteins exist predominantlypate in HIV release, we identified 22 candidate human
class E proteins. These proteins were connected into as soluble proteins or subcomplexes that are sequen-
tially recruited from the cytoplasm to function at sites ofa coherent network by 43 different protein-protein
interactions, with AIP1 playing a key role in linking MVB vesicle formation (termed ESCRTs, for Endosomal
Sorting Complexes Required for Transport) (Babst etcomplexes that act early (TSG101/ESCRT-I) and late
(CHMP4/ESCRT-III) in the pathway. AIP1 also binds al., 2002a, 2002b; Katzmann et al., 2003; Odorizzi et al.,
2003). After proteins are sorted into MVB vesicles, thethe HIV-1 p6Gag and EIAV p9Gag proteins, indicating that
it can function directly in virus budding. Human class E assembled class E proteins are then released upon ATP
binding/hydrolysis by the AAA ATPase, Vps4p. Thus,proteins were found in HIV-1 particles, and dominant-
negative mutants of late-acting human class E pro- the different factors and stages of yeast MVB biogenesis
are now understood in outline. The present studies wereteins arrested HIV-1 budding through plasmal and en-
dosomal membranes. These studies define a protein undertaken with the goals of defining the network of
proteins required for human MVB biogenesis and testingnetwork required for human MVB biogenesis and indi-
cate that the entire network participates in the release whether HIV-1 budding requires the function of proteins
that act later in this pathway.of HIV and probably many other viruses.
Introduction Results
HIV spreads via extracellular particles that can enter Modeling the Human Protein Interaction Network
and exit cells. The characterization of viral and cellular Required for MVB Biogenesis
proteins involved in HIV entry has provided a greater A systematic search for human homologs of yeast class
understanding of early stages in the viral life cycle, and E proteins yielded at least one acceptable match for all
led to new therapeutics (Biscone et al., 2002). In con- 17 yeast proteins, with the exception of Vps37p (Figure 1
trast, the equally important process of HIV release is and Supplemental Table S1 available at http://www.cell.
less well understood, and many of the cellular factors com/cgi/content/full/114/6/701/DC1). The resulting 22
involved in this fundamental stage of the viral life cycle human proteins can be grouped in analogy to the yeast
remain to be identified and characterized (for recent ESCRT subcomplexes, and the groupings shown in Fig-
reviews see Freed, 2002; Pornillos et al., 2002c). ure 1A are consistent with studies in mammalian sys-
Efficient HIV release requires the cis-acting, tetrapep- tems indicating that: (1) HRS, STAM1/2, TSG101, and
tide P(S/T)AP “late domain” found in the p6 domain of VPS28 all act early in MVB formation (Asao et al., 1997;
all HIV Gag proteins, and also in the structural proteins Babst et al., 2000; Bache et al., 2003a, 2003b; Bishop
et al., 2002; Bishop and Woodman, 2001; Lu et al., 2003;
Pornillos et al., 2003), and (2) the ESCRT-II proteins*Correspondence: wes@biochem.utah.edu
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702
Figure 1. Model for the Human Class E Protein Interaction Network
(A) Schematic illustration showing 22 putative human class E proteins, their subcomplexes, and interactions. Interactions between proteins
are denoted by arrows and are color-coded as previously known (black) or novel (red). ESCRT-I, II, III complexes are modeled after analogous
yeast complexes (Katzmann et al., 2002). Detection methods, interactions (in brackets) and relevant protein fragments (in parentheses) were:
a) Yeast two-hybrid screens of cDNA libraries: [6] (TSG101317–390/VPS2810–221), [11] (TSG1011–266/AIP1584–868), [19] (EAP3043–258/CHMP61–130), [20]
(EAP45317–386/CHMP61–130); b) Directed yeast two-hybrid screens [4, 6, 8–9, 11–12, 15–18, 21–30, 32–35, and 38–41] (all full-length proteins); c)
Interactions between purified proteins detected using GST pull-down assays: [13] (AIP11–716/EIAV p9), [14] (AIP1–716/HIV-1 p6), [16] (AIP11–716/
CHMP4B), and [9, 30–32, 36–37, 42–43] (all full-length proteins); d) Interactions between purified proteins detected using Biacore biosensor:
[11] (Tsg1011–145/AIP1714–723). References for previously reported interactions are: [1] and [2] (Asao et al., 1997), [3] (Bache et al., 2003a; Lu et
al., 2003; Pornillos et al., 2003), [4] (Martin-Serrano et al., 2003), [5] (Demirov et al., 2002a; Garrus et al., 2001; Martin-Serrano et al., 2001;
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form a stable complex in mammalian cells (Kamura et and CHMP2B did not show any positive interactions.
Our experiments reconfirmed several yeast two-hybridal., 2001).
In several cases, a single yeast protein apparently has interactions described previously in mammalian sys-
tems: TGS101/TSG101 (Martin-Serrano et al., 2003),two or more human orthologs, implying greater com-
plexity in the mammalian MVB pathway. This is most TSG101/VPS28 (Bishop and Woodman, 2001), AIP1/
AIP1 (Chatellard-Causse et al., 2002), CHMP1A/VPS4B,evident late in the pathway; e.g., the single yeast Vps4p
protein has two apparent human orthologs: VPS4A and and CHMP2A/VPS4B (Howard et al., 2001). We also
found a series of interactions that were previously un-VPS4B, and the six related proteins of the yeast ESCRT-
III class have 10 apparent human orthologs, the charged documented in mammalian systems, but were analo-
gous to interactions previously described in yeast (e.g.,MVB proteins or CHMP proteins. The six yeast proteins
perform distinct functions: two (Vps32p/Snf7p and CHMP4B/CHMP6, AIP1/CHMP4A-C) (Babst et al., 2002a;
Odorizzi et al., 2003), or were consistent with biochemi-Vps20p) form a proximal lattice that binds directly to the
MVB membrane, two (Vps2p/Did4p and Vps24p) form a cal or genetic experiments in yeast (e.g., ESCRT-I re-
cruits ESCRT-II to the endosomal membrane (Babst etdistal layer on the first, and the remaining two (Did2p
and Vps60p/Mos10p) apparently have partially redun- al., 2002b), Snf7p (CHMP4A-C) recruits Bro1p (AIP1)
(Odorizzi et al., 2003), and ESCRT-II recruits Vps20pdant and/or regulatory roles (Babst et al., 2002a). A phy-
logenetic analysis showed that the 10 related human (CHMP6) (Babst et al., 2002b). It is therefore apparent
that the MVB pathway is conserved in outline from yeastCHMP proteins can also be subdivided into six analo-
gous groups (Figure 1A and Supplemental Figure S1 to man.
Importantly, our two screens revealed 25 new classavailable on Cell website).
E protein-protein interactions that had not previously
been described in any system. These included the firstProtein Interactions within the Human Vps Class
E Protein Network links between ESCRT-I and ESCRT-II (TSG101/EAP45,
TSG101/EAP30), and between ESCRT-I and AIP1Extensive yeast two-hybrid analyses were performed to
test our model for the human MVB pathway and to iden- (TSG101/AIP1). Collectively, our data imply a hierarchy
of protein interactions required for MVB formation, withtify new protein-protein interactions that could link the
entire protein network together, which has not been HRS complex recruiting ESCRT-I; ESCRT-I recruiting AIP1
and ESCRT-II; AIP1 and ESCRT-II recruiting ESCRT-III;possible in any system including yeast. Potential inter-
actions between human class E proteins were tested and ESCRT-III recruiting VPS4A/B (see Figure 1A).
using both random library screening and directed yeast
two-hybrid assays, which provided overlapping and TSG101/AIP1 Interactions
The novel interaction between TSG101 and AIP1 de-complementary information (Figure 1, Supplemental
Figure S1 and Table S1 available on Cell website). In tected in the yeast two-hybrid experiments was charac-
terized in greater detail because it provided, to ourthe random screen, early (TSG101) and late (CHMP6)
acting class E proteins were used as baits in automated knowledge, the first direct link between the human
ESCRT-I and ESCRT-III complexes. Deletion analysesscreens of human cDNA libraries, with multiple con-
structs employed to identify interacting domains. These revealed that the N-terminal UEV domain of TSG101
(residues 1–145) bound the proline-rich C-terminal re-screens confirmed one previously known TSG101 inter-
action, TSG101/VPS28 (Bishop and Woodman, 2001), gion of AIP1 (residues 586–868) (Figures 1B and 2A).
The TSG101 UEV domain binds specifically to P(S/T)APand revealed three novel interactions: TSG101/AIP1,
CHMP6/EAP30, and CHMP6/EAP45. All four interactions sequences, but a mutation in the UEV domain (M95A)
abolishes P(S/T)AP binding (Pornillos et al., 2002a,were confirmed in semiquantitative liquid -galactosi-
dase two-hybrid assays (Figure 1B). 2002b). The M95A mutation also eliminated AIP1 binding
to both the full-length and TSG1011–145 proteins (FigureThe directed screen tested for all possible intra- and
intermolecular interactions between the 18 human class 2A, far right, red bar), indicating that the TSG101 UEV
domain bound a P(S/T)AP-like sequence in the proline-E proteins predicted to act downstream of TSG101 (in-
cluding TSG101 itself). A total of 28 interactions were rich region of AIP1.
There is a conserved PSAP motif within the proline-identified and 16 of the 18 proteins tested interacted
with at least one other class E protein (Figures 1A and rich region of AIP1 (residues 717–720), and we therefore
tested whether the TSG101 UEV domain could bind this1C). CHMP5 constructs were toxic or self-activating,
VerPlank et al., 2001), [6] (Bishop and Woodman, 2001), [7] (Kamura et al., 2001), [8] and [9] (Howard et al., 2001), [10] (Scheuring et al., 2001),
[12] (Chatellard-Causse et al., 2002) and [14] (Strack et al., 2003).
(B) Protein-protein interactions detected in yeast two-hybrid library screens and confirmed using semiquantitative -galactosidase assays.
Positive signals from yeast expressing prey-AD/bait-BD pairs (black bars) are shown together with signals from control cells expressing AD/
bait-BD (yellow) and prey-AD/BD pairs (blue). Interaction numbers (below) correspond to those in Figure 1A, and the HRS/TSG101 interaction
served as a positive control (Pornillos et al., 2003). Signals were normalized relative to the appropriate positive signal (given in fluorescence
units adjacent to black bars).
(C) Directed yeast two-hybrid interactions between human class E proteins detected in X--gal assays. From left to right, each image shows
X--gal signals from yeast patches containing AD/bait-BD (negative control), prey-AD/BD (negative control), and prey-AD/bait-BD (positive
interaction). All interactions shown were positive in multiple repetitions of these experiments and are denoted as strong (s, signal in 1–2 days),
medium (m, signal in 3 days), and weak (w, signal in 4 or more days). Very weak interactions not scored as positive were: CHMP3/CHMP4B,
CHMP1B/VPS4B, CHMP4B/EAP45, and CHMP6/VPS4A. Note that some two-hybrid interactions could be mediated via bridging yeast proteins.
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Figure 2. TSG101/AIP1 Interactions
(A) -galactosidase assays showing two-
hybrid interactions between AD/TSG1011–145-
BD (yellow, negative control), AIP1-AD/BD
(blue, negative control), AIP1-AD/TSG1011–145-
BD (black), AD/M95A-TSG1011–145-BD (green,
negative control), and AIP1-AD/M95A-
TSG1011–145-BD (red).
(B) Biosensor binding isotherms for GST-
AIP1714–723 binding to wt (squares, KD  142 
0.5 M) or M95A mutant (ovals) TSG101 UEV.
Raw binding data for this figure are given in
Supplemental Figure S2A (available on Cell
website).
motif directly using Biacore biosensor experiments. and -CHMP5 were poorly soluble and therefore not
tested). As shown in Figure 3A, AIP11–716 bound CHMP4B,Pure recombinant TSG101 UEV domain bound specifi-
cally to a peptide spanning AIP1 residues 714–723 (de- but not the other CHMP proteins. A single point mutation
(L217A) near the C terminus of CHMP4B blocked AIP1noted AIP1714–723; KD  142  0.5 M), and binding was
again eliminated by the TSG101 M95A mutation (Figure binding (Figure 3A, compare lanes 7 and 8). Although
the functional interactions between AIP1 and CHMP42B and Supplemental Figure S2A available on Cell web-
site). Hence, the TSG101 UEV domain binds directly to proteins presumably occur primarily within membrane
bound complexes, it was possible to coimmunoprecipi-the 717PSAP720 element of AIP1.
tate AIP1-Myc and CHMP4B-FLAG proteins that were
overexpressed in 293T cells (Figure 3B). Overall, weAIP1/CHMP4 Interactions
The yeast two-hybrid data also indicated that AIP1 inter- conclude that AIP1 binds directly and specifically to
the CHMP4 proteins, but not to CHMP proteins fromacts with all three members of the CHMP4 family of
ESCRT-III proteins, but not with other CHMP proteins. other families.
GST pull-down assays were performed to test for direct,
specific protein-protein interactions between AIP11–716 Interactions of AIP1 and Viral Proteins
Recent evidence suggests that AIP1 may play a directand representatives from 5 of the 6 different CHMP sub-
classes (1B, 2A, 3, 4B, and 6; GST-CHMP4A, -CHMP4C, role in the release of several enveloped viruses, includ-
Figure 3. CHMP Protein Interactions
(A) CHMP/AIP1 interactions analyzed in GST
pull-down assays. Excess pure AIP11–716 (lane
1, 10% of input) was incubated with glutathi-
one beads prebound with different GST fusion
proteins (lanes 2–10, lower bands). Bound
AIP1–716 was separated by SDS-PAGE and vis-
ualized by Coomassie blue staining (upper
bands in lanes with asterisks).
(B) Coimmunoprecipitation of CHMP4B and
AIP1. 293T cells were cotransfected with
AIP1-Myc expression vector and with either
pcDNA3.1 control vector (lane 1) or CHMP4B-
FLAG expression vector (lane 2). Proteins
were immunoprecipitated (IP) from the ly-
sates using anti-FLAG antibodies and de-
tected by Western blotting with anti-Myc (top
image) or anti-FLAG (middle image). A West-
ern blot (anti-Myc) of the soluble lysate is
shown in the bottom image (1% input).
(C) CHMP/VPS4 interactions analyzed by
GST pull-down assays. Pure VPS4A or VPS4B
(lanes 1 and 2; 0.7 g, 5% of input, 10-fold
molar excess) were incubated with glutathi-
one beads prebound with GST alone (lanes
3 and 4), GST-CHMP1B (lanes 6 and 7), or GST-
CHMP2A (lanes 9 and 10). GST-CHMP1B and
GST-CHMP2A alone are shown in lanes 5 and
8, respectively. Note that GST-CHMP1B/
VPS4A and GST-CHMP2A/VPS4B comigrate
in lanes 6 and 10, respectively.
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Figure 4. Virion Incorporation and HIV-1 Gag Redistribution to Class E Compartments
(A) Cellular and HIV-1-associated proteins detected by Ponceau S staining (upper left blot) and Western blotting with the indicated antibodies.
Lanes labeled “cells” correspond to extracts from 105 uninfected MT4 cells (positive control), lanes labeled “CA” correspond to 1 g pure CA
(negative and loading control). Lanes labeled virions 1–3 correspond to independent preparations of purified HIV-1 particles (1g CA equivalent),
sample 2* was treated with subtilisin. Recombinant AIP1–716 and VPS4B protein standards are also shown. Full-length AIP1 protein (arrowhead)
is 868 amino acids long, and the presence of multiple bands in the cell and virion lanes presumably reflects multiple protein isoforms,
posttranslational modification, degradation products, and/or crossreacting proteins.
(B) Confocal fluorescence microscopic images showing the distribution of CHMP4B (first column, red) and Gag-GFP or GagPTAP-GFP
(second column, green) in cells expressing CHMP4B-FLAG (top row, negative control) or dominant-negative DsRed-CHMP4B (middle and
lower rows). Overlaid red and green images at right show colocalization at the class E compartment of DsRed-CHMP4B with Gag-GFP (yellow
arrow). White cross bars mark the directions of the reslicing done in the XZ (bottom inset) and YZ planes (right inset). Single Z-sections are
shown in the first three columns, and merged Z-stacks (“merged overlay”) are shown in the fourth. Scale bar is 10 m.
ing HIV-1. As shown above, AIP1 binds directly to et al., 2003). We have confirmed their observation and
shown that both conserved leucines are required for fullTSG101, which in turn binds the 7PTAP10 late domain
of HIV-1 p6Gag and facilitates virus budding. Moreover, affinity AIP1 binding (Supplemental Figure S2B available
on Cell website). It is therefore likely that Gag forms aGo¨ttlinger and coworkers now report that AIP1 can bind
directly to a downstream 41LRSL44 motif within p6 (Strack ternary complex with both TSG101 and AIP1 during viral
Cell
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Figure 5. HIV-1 Release and Infectivity Are
Inhibited by Dominant-Negative CHMP and
VPS4B Proteins
Analyses of HIV-1 Gag protein expression
(Western blot, middle image), virion release
(top image), and viral infectivity (lower image)
in the presence of the dominant-negative
CHMP and VPS4B proteins: (A) CFP-CHMP4C,
DsRed-CHMP4B, DsRed-CHMP2A or CHMP-
YFP and (B) mutant VPS4B proteins. Levels
of cytoplasmic Gag proteins relative to the
relevant controls were determined by inte-
grating the CA and MA band intensities in
lighter exposures (numbers given at bottom
of the blot). Note the characteristic late defect
in intracellular processing of the CA-p2 pro-
tein seen in all cases where virus release is
inhibited. Viral titers were determined in sin-
gle-cycle MAGI infectivity assays of superna-
tants from transfected cells (blue cells/0.1
ml supernatant).
budding. However, mutations that disrupt the TSG101/ CHMP Proteins Bind VPS4 Proteins
Yeast two-hybrid interactions linked many of theGag interaction typically inhibit HIV-1 release to a much
greater extent than do mutations that disrupt the AIP1/ ESCRT-III/CHMP proteins to the two human VPS4 pro-
teins, and we therefore tested whether recombinantGag interaction, indicating that the class E proteins are
probably recruited primarily through the TSG101/Gag VPS4 and CHMP proteins could interact directly. As
shown in Figure 3C, pure recombinant mammalianinteraction (Demirov et al., 2002b; Go¨ttlinger et al., 1991).
It has also been suggested that AIP1 may bind to the VPS4A and VPS4B proteins bound to GST-CHMP1B
(lanes 6 and 7) and GST-CHMP2A (lanes 9 and 10) butYPDL late domain found in the p9 domain of the equine
infectious anemia virus (EIAV) Gag (Vincent et al., 2003). not to GST alone (lanes 3 and 4). Analogous VPS4 bind-
ing interactions were also seen for the two other CHMPAlthough AP-2 was initially described as a cellular bind-
ing partner for the YPDL late domain (Puffer et al., 1998), proteins tested (CHMP4B and CHMP6, data not shown).
These observations imply that, as in yeast (Babst et al.,this has been puzzling because AP-2 functions primarily
in endocytosis rather than MVB formation. More re- 2002a), the mammalian VPS4 enzymes likely act directly
on the subunits of the CHMP protein lattice.cently, however, AIP1 has been proposed as an alterna-
tive binding partner for the EIAV late domain because
AIP1 orthologs from several organisms can bind YPXL HIV-1 Packaging and Gag Colocalization
of Human Class E Proteinssequences (Vincent et al., 2003). We therefore tested
whether AIP1 and EIAV-p9 could form a complex in vitro. Cellular factors that participate in viral budding may be
packaged into virions, and we have previously shownAs shown in Figure 3A (lane 9), AIP11–716 bound GST-p9
and this interaction was specific for the p9 23YPDL26 late that the ESCRT-I proteins TSG101 and VPS28 are specif-
ically packaged into HIV-1 virions (J.E. Garrus, K.M.domain motif, because binding was abolished (lane 10)
by a mutation of the central proline residue (P24A) that Stray, B.M., H.-G.K., and W.I.S., unpublished data). Pro-
teins that act later in the MVB pathway have not yet beenalso inhibits EIAV release (Puffer et al., 1997). Thus, AIP1
can bind both HIV-1 p6 and EIAV p9, indicating that both tested for virion incorporation, however. We therefore
analyzed purified HIV-1 particles from acutely infectedviruses enter the mammalian class E protein network,
at least in part, through direct interactions with AIP1. human MT4 cells for the presence of AIP1, CHMP1A,
Human Class E Proteins and HIV Budding
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CHMP2A, VPS4A, and VPS4B. The purity of the virion ized to the class E compartments induced by expression
of the DN VPS4-E235Q protein (Supplemental Figure S4preparations was evaluated on silver stained SDS-gels
(not shown) and by Western blotting, which revealed available on Cell website).
Gag-GFP redistributed significantly from the plasmano detectable contamination with a series of cellular
proteins such as the abundant 14-3-3 protein (Figure membrane/cell periphery into class E compartments
upon expression of either DsRed-CHMP4B (Figure 4B)4A, bottom right and data not shown; see also Muller
et al., 2002). or VPS4B-E235Q (data not shown). Similar results were
obtained for dominant-negative versions of the CHMP2AAll of the proteins tested were readily detected in cell
extracts (Figure 4A and data not shown). However, only and VPS4A proteins (data not shown). Moreover, the
degree to which Gag-GFP redistributed apparently de-AIP1 and VPS4B were present in multiple independent
preparations of HIV-1 particles, with a significantly pended upon TSG101 binding to Gag, as colocalization
of wt Gag-GFP/DsRed-CHMP4B was observed in 68%stronger signal for AIP1 (Figure 4A, lanes labeled virions
1, 2*, and 3). Subtilisin treatment, which degrades pro- of the cells examined (n  19), whereas colocalization
of mutant GagPTAP-GFP/DsRed-CHMP4B was un-teins on the virion exterior (Ott et al., 2000), did not
significantly reduce the AIP1 or VPS4B signals (lanes common (18%, n  48; Figure 4B, bottom image). Our
data therefore support a model in which nonfunctionallabeled virions 2*), indicating that these proteins were
located inside the viral particles. Absolute levels of vi- CHMP and VPS4 proteins cause Gag proteins to accu-
mulate together with TSG101 and other trapped classrion-associated proteins were estimated by comparing
virus-associated CA, AIP1, and VPS4B proteins against E proteins on the surface of aberrant late endosomal
compartments.known quantities of recombinant proteins. 5–10 ng of
AIP1 and 0.1–0.5 ng of VPS4B per g of CA were de-
tected. Assuming that there are 5000 Gag molecules Dominant-Negative CHMP and VPS4B Proteins
per virion (V. Vogt, personal communication), this implies Block HIV-1 Release and Infectivity
that, on average, 3–12.5 molecules of AIP1 and 0.5–2.5 The functional involvement of the CHMP and VPS4B
molecules VPS4B were incorporated into each viral proteins in HIV-1 release was also tested using domi-
particle. nant-negative proteins. A DN CHMP1A protein can be
created by fusing large polypeptides to the protein’s C
terminus (Howard et al., 2001). We found, however, thatThe PTAP Late Domain Helps Target HIV-1 Gag
to Mammalian Class E Compartments many such CHMP fusion constructs were cytotoxic and
reduced Gag protein expression. We therefore surveyedIn most cell lines, HIV-1 Gag is released primarily from
the plasma membrane, whereas in macrophages the a series of 25 N- and C-terminal CHMP fusion proteins
for the ability to inhibit virus release without stronglyvirus buds directly into MVB/late endosomal compart-
ments (Pelchen-Matthews et al., 2003; Raposo et al., reducing Gag expression (see Supplemental Table S2
available on Cell website).2002). These two observations can be unified by a model
in which: (1) Gag is targeted to the late endosome As shown in Figure 5A, HIV-1 release was dramatically
inhibited by coexpression with CFP-CHMP4C, DsRed-through interactions with the class E proteins; (2) Gag
then traffics to the plasma membrane via an endosomal CHMP2A, DsRed-CHMP4B, and CHMP3-YFP. Virus re-
lease was analyzed by: (1) Western blot detection ofpathway; and (3) viral budding can occur at different
stages along this pathway depending on the cell type. virion-associated MA and CA proteins released by cells
expressing HIV-1 (upper images), and (2) reductions ofThis model suggests that HIV-1 Gag may accumulate
on endosomal membranes upon arrest of MVB forma- viral titers in single cycle MAGI assays (lower images).
Intracellular Gag protein expression was analyzed bytion, as is the case for the class E proteins themselves
(see Supplemental Figure S3 available on Cell website). Western blot detection of cytoplasmic MA and CA pro-
teins (middle images). Controls for these experimentsTo test this idea, we examined whether dominant-
negative CHMP4B and VPS4B proteins altered HIV-1 included the appropriate empty vectors (negative con-
trols) and HIVPTAP mutants (positive controls for ar-Gag-GFP localization. A dominant-negative (DN) VPS4B
protein was created by mutating residues required for rested HIV-1 budding).
The most dramatic effects were observed for the CFP-ATP binding (K180Q) or hydrolysis (E235Q) (see also
Fujita et al., 2003), and a dominant-negative CHMP4B CHMP4C construct, which did not alter cellular Gag
expression levels, but reduced virus release to nearlyprotein was created by fusing DsRed to the protein’s N
terminus (Howard et al., 2001). The expected class E undetectable levels in the Western blot assay and re-
duced the release of infectious virus more than 30-fold.phenotypes induced by expression of VPS4B-K180Q,
VPS4B-E235Q, and DsRed-CHMP4B were confirmed in DsRed-CHMP2A, DsRed-CHMP4B, and CHMP3-YFP
also reduced viral infectivity significantly (10-, 17-, anda series of control experiments showing that: (1) the
DN VPS4B proteins inhibited ligand-induced lysosomal 73-fold, respectively), albeit with modest reductions in
Gag protein expression (2- to 3-fold).degradation of surface MHC-I and EGFR proteins (Sup-
plemental Figure S3A–S3F available on Cell website); Coexpression of the dominant-negative VPS4B pro-
teins inhibited virus release 100-fold for both mutants(2) the DN VPS4B and CHMP4B proteins induced forma-
tion of aberrantly enlarged, vacuolated “mammalian (Figure 5B), although Gag expression levels were again
reduced modestly (2- to 3-fold in the Western blot assay,class E” compartments that stained positive for both
lysosomal and endosomal markers (Supplemental Fig- middle image). In contrast, the wt VPS4B (negative con-
trol) produced a comparable 2-fold reduction in cellularure S4 available on Cell website); and (3) the soluble,
nondominant-negative CHMP4B-FLAG protein relocal- Gag expression levels, but with no additional reduction
Cell
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Figure 6. HIV-1 Budding Arrest Induced by Dominant-Negative CHMP and VPS4B Proteins
EM images of thin-sectioned 293T cells transfected with HIV alone (A), HIVPTAP (B), or HIV and dominant-negative DsRed-CHMP4B (C and
D), DsRed-CHMP2A (E), or DsRed-VPS4B-E235Q (F–P). Thick scale bars are 1 m; thin scale bars are 100 nm. Open arrows indicate virions
arrested in budding at the plasma membrane; arrowheads indicate thickened protein coats on plasma or endosomal membranes; and black
arrows indicate striations in the stalks of arrested virions. n: nucleus; e: highly vacuolated class E compartment.
in viral titer (3.5-fold). These data demonstrate that the negative CHMP2A, CHMP4B, and VPS4B proteins. Thin-
sectioned 293T cells transfected with wt HIV-1 DNAdominant-negative CHMP and VPS4 proteins diminish
particle release and infectivity very significantly, indicat- alone displayed very few cell-associated virions, and
these typically exhibited the conical viral cores that areing that they likely play a functional role in HIV-1 release.
the hallmark of the mature infectious virus (Figure 6A). In
contrast, coexpression of HIV-1 with dominant-negativeDominant-Negative VPS4B and CHMP Proteins
Arrest HIV-1 Budding at a Late Stage DsRed-CHMP2A, DsRed-CHMP4B, or VPS4B proteins
caused viruses to arrest at a very late stage in assembly,Electron microscopy was used to determine the stage
at which virus release was arrested by the dominant- in which extensive clusters of immature particles accu-
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mulated at the plasma membrane but remained con-
nected via membrane stalks (Figure 6, open arrows).
This arrest resembled a late domain phenotype, except
that GagPTAP mutants frequently arrested at a some-
what earlier stage (often following membrane distortion,
but prior to stalk formation; Figure 6B and see Garrus
et al., 2001), suggesting that virus release may proceed
through multiple stages and that the dominant-negative
VPS4B, CHMP4B, and CHMP2A proteins inhibited a very
late step(s) in release.
Cells coexpressing HIV-1 and VPS4B-E235Q proteins
Figure 7. Schematic Model for the HIV-1 Budding Arrest Inducedexhibited aberrant clusters of tubules and vacuoles that
by Expression of Dominant-Negative VPS4 Proteinswere not observed in control cells. These presumably
The illustration emphasizes how nascent viral particles arrest to-corresponded to the class E compartments seen by
gether with class E protein complexes at both endosomal andfluorescence microscopy (Figures 6F–6H, labeled “e”
plasma membranes when VPS4 proteins are unable to hydrolyze
and see Supplemental Figure S4 available on Cell web- ATP (denoted by the black X). Proteins and complexes are color-
site). Strikingly, we frequently observed HIV particles coded as in Figure 1A. The figure is simplified in that oligomeric
arrested in the process of budding into the vacuoles proteins are represented only once (e.g., Gag, TSG101, AIP1, and
CHMP proteins), only the plasma membrane arrest is shown, andassociated with these compartments (Figures 6G and
many temporal and spatial details of the illustrated interactions re-6H) as well as into other, smaller clusters of intracellular
main to be elucidated.vacuoles (Figures 6I, 6J, and 6P). Viruses arrested while
budding through intracellular and plasma membranes
were morphologically indistinguishable, and we there- indicating that VPS4B acts near sites of viral assembly
fore conclude that VPS4B-E235Q imposes similar and release. Although additional studies will be required
blocks at internal and external membranes. to understand HIV-1 release in molecular detail, the ap-
The size and appearance of the internal compart- parent requirement for more than 20 cellular proteins in
ments varied considerably, as did the morphologies of this essential viral process provides many potential new
the arrested virions (e.g., in content and in stalk length targets for therapeutic intervention.
and width). Nevertheless, there were two indications Our studies also begin to define the different roles of
that cellular protein complexes might be functioning at human class E proteins in MVB biogenesis. As in yeast,
the sites of viral budding. Firstly, we and others often human CHMP6 appears to be recruited by the ESCRT-
observed a thickening of the cytoplasmic faces of mem- II complex, whereas the CHMP4 proteins are recruited
branes near sites of virus budding, which may corre- by AIP1 (see Figures 1 and 7) (Babst et al., 2002b; Odo-
spond to the ESCRT-III protein coat (see Figures 6H, 6I, rizzi et al., 2003). Importantly, we also found that TSG101
6L and 6P, arrowheads) (Pelchen-Matthews et al., 2003). and AIP1 make a series of key interactions along the
Secondly, ring-like striations were sometimes observed MVBpathway: HRS/TSG101→TSG101/EAP30,45;TSG101/
within the membrane stalks of viruses arrested by the AIP1→AIP1/CHMP4A-C that collectively link the human
dominant-negative VPS4B-E235Q protein (Figures 6K– HRS, ESCRT I, II, and III complexes (Bache et al., 2003a;
6P, highlighted by black arrows). These striations were Pornillos et al., 2003, and this work).
not observed for PTAP viruses (which are presumably It is striking that the UEV domain of TSG101 can bind
defective in recruiting TSG101 and other class E proteins to PTAP motifs found in three different proteins in the
and rarely showed narrow membrane stalks). We there- pathway (HRS, TSG101 itself, and AIP1) (Bache et al.,
fore speculate that the membrane coats and/or stria- 2003a; Katzmann et al., 2003; Lu et al., 2003; Pornillos
tions may represent trapped cellular machinery that et al., 2003) as well as in the HIV-1 p6Gag protein (Demirov
might normally help to catalyze protein sorting, mem- et al., 2002a; Garrus et al., 2001; Martin-Serrano et al.,
brane fission, and/or virus release from wild-type cells. 2001; VerPlank et al., 2001). TSG101 could, in principle,
bind multiple partners simultaneously as it self-oligo-
merizes in two-hybrid assays (Figures 1A and 1C). Alter-Discussion
natively, TSG101 may bind sequentially to the different
PTAP elements, producing conformational changes thatOur experiments define the human class E protein net-
work and strongly support the idea that HIV-1 utilizes could give directionality to the pathway. In either case,
we speculate that viral protein binding to the recognitionthis entire network during viral egress (see Figure 7).
Most importantly, HIV-1 release can be arrested at a domains of TSG101 and AIP1 may serve not only to
recruit the machinery of vesicle formation, but also tolate stage by deletion or mutation of at least 8 different
human class E proteins, which function both early alter normal protein-protein interactions required during
protein sorting and MVB vesicle formation. This could(TSG101, VPS28) (Garrus et al., 2001; Martin-Serrano et
al., 2001, 2003), and late (CHMP2A, CHMP3, CHMP4B, activate the vesicle fission machinery and/or allow viral
proteins to substitute for cellular protein cargos.CHMP4C, VPS4A, VPS4B) in the MVB pathway. In addi-
tion, HIV-1 particles package multiple copies of proteins Although it is not yet clear where HIV-1 Gag first meets
(or recruits) the human class E proteins, the retroviralthat act both early (TSG101, VPS28), and later (AIP1) in
the MVB pathway. They are also enriched in at least one Moloney Murine Leukemia Gag protein traffics along
endosomal membranes before appearing at the plasmaprotein that functions very late in the pathway (VPS4B),
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membrane (Basyuk et al., 2003). Moreover, several known late domains (PTAP, PPXY, YPDL, and/or LXXL)
groups have demonstrated that in macrophages, HIV-1 (Garrus et al., 2001; Martin-Serrano et al., 2003).
buds primarily into intracellular compartments that cor- In conclusion, multiple classes of enveloped viruses
respond to multivesicular bodies (Pelchen-Matthews et utilize the unique budding topology of MVB vesicles as
al., 2003; Raposo et al., 2002). Our studies also support a nonlytic mechanism for escaping cells. Here, we have
a role for endosomal compartments in both Gag traffick- identified an extensive network of human proteins in-
ing and virus budding. Specifically, we find that even volved in both cellular protein trafficking and virus re-
in nonmacrophage lineages (293T cells), where viruses lease, setting the stage for understanding how these
seem to bud predominantly from the plasma membrane, proteins help catalyze protein sorting, membrane defor-
induction of a class E phenotype causes HIV-1 Gag to mation, and fission from the cytoplasmic face of a bud-
concentrate and arrest while budding into class E com- ding vesicle or virus.
partments.
Intracellular budding is particularly noticeable under
Experimental Proceduresclass E conditions because arrested viral particles accu-
mulate on membranes, and possibly also because the
Yeast Two-Hybrid Experiments
trapped class E proteins may recruit Gag more efficiently Directed two-hybrid assays with full-length human class E genes
than in wild-type cells (where the class E proteins are (Supplemental Table S1 available at Cell website) were performed
using the Matchmaker GAL4 Yeast Two-Hybrid 3 system (Clontech).predominantly cytosolic). Nevertheless, we and others
Library screening was performed as described (Garrus et al., 2001),(Sherer et al., 2003; M. Thali, personal communication)
with eleven different TSG101 and four different CHMP6 baitshave observed intracellular HIV-1 budding even in wild-
screened against 3-11 106 activation domain (AD) fusions derivedtype 293T cells, particularly with the HIVPTAP mutant
from human spleen, brain, and macrophage cDNA libraries.
(which again facilitates visualization because the viruses Two-hybrid interactions were tested in -Leu, -Trp, -Ade, -His,
arrest while budding). Conversely, we (and many others) X--gal (50 g/mL) plate assays (Figure 1C) or in semiquantitative
have observed wt virus in the process of budding di- liquid culture -galactosidase activity assays (Figure 1B). In liquid
assays, yeast transformants were picked and grown in 100 l (-Leu,rectly from the plasma membranes of 293T and HeLa
-Trp) SD media in 96 well flat-bottomed plates to an average A610cells (e.g., see Supplemental Figure S5 available on Cell
of 0.4. Resorufin -D-galactopyranoside (RDG) assay solutionswebsite). It therefore appears that HIV-1 can bud into
were 1:1 mixtures of: (1) 25 mM PIPES, [pH 7.2]; 10 mM RDG, andboth internal endosomal and plasma membranes, and
(2) 250 mM PIPES, [pH 7.2]; 10% NP-40; 0.24 Units/ml lyticase. 20
the degree to which the alternate sites are utilized in l of the RDG mix was added to each well, and fluorescence was
different cell types may simply reflect differences in the measured after 0 and 1–2 hr of incubation at 37	C (SpectraMAX
GeminiXS, Molecular Devices, Inc. Sunnyvale, CA; excitation at 566relative rates of virus budding versus Gag trafficking to
nm, emission at 628 nm, with a 610 nm cutoff filter).the plasma membrane. Importantly, virions that bud into
intracellular compartments can still emerge from the cell
via the exosome pathway, i.e., when the limiting MVB
Protein Expression and Purification
membranes fuse with the plasma membrane and release Expression Constructs
their vesicles (or viruses) as exosomes (Denzer et al., The EIAV p9 gene was PCR-amplified as an NdeI–BamHI-fragment
2000; Pornillos et al., 2002c; Raposo et al., 2002). The from a proviral EIAVUK plasmid (a gift from Frank Cook, University
of Kentucky) (Cook et al., 1998). Other genes were amplified byparallels between exosomes and viruses are further em-
PCR (with the first 5 codons optimized for E. coli expression) fromphasized by the fact that AIP1 and TSG101, as well as
templates listed in Supplemental Table S1 (available on Cell web-MLV Gag proteins, are found in preparations of murine
site). Genes were subcloned into the NdeI/BamHI sites of a modified
exosomes (Thery et al., 2001). A full discussion of the pGEX2T vector (WISP01-69, for GST fusion proteins) or pET11a
potential relationships between exosomes and viruses (Novagene, for AIP11–716) and verified by sequencing. AIP11–716 lacked
is given in Gould et al. (2003). the proline-rich region, which hindered expression of full-length
AIP1. Mutations were introduced by PCR megaprimer mutagenesis.It will be of interest to understand what factors influ-
Protein Expressionence where the virus buds, how Gag traffics via the
BL21(DE3) E. coli cells were grown to mid log, induced with 0.5 mMendosomal network to the plasma membrane, and
IPTG, and recombinant proteins were allowed to accumulate forwhether viruses can control these events. These issues
2–4 hr (23	C). Cells were harvested, lysed using lysozyme (10 g/l
could impact viral pathogenesis because endosomal culture) and sonication, and insoluble material was removed by
pathways could be used to promote directional release centrifugation (30 min at 25,000  g).
(e.g., see Igakura et al., 2003; McDonald et al., 2003) GST fusion proteins were purified by glutathione affinity chroma-
tography, cleaved to remove glutathione, and repurified by conven-and because the primary sites of virus release likely
tional chromatography (Pornillos et al., 2002a). Untagged AIP11–716change during AIDS disease progression as the tropism
was precipitated with 55% saturated ammonium sulfate after a 27%of the virus evolves from macrophages (internal bud-
precut, redissolved in 25 mM MOPS [pH 7.0], 5 mM -ME, and
ding) to T cells (plasma membrane budding). purified by Q-Sepharose chromatography (Amersham Pharmacia;
A final important finding implied by this and related elution at 250 mM NaCl from a linear gradient of 0–1 M over 400
work is that multiple different classes of enveloped vi- mL). Fractions containing AIP11–716 were pooled, adjusted to 1 M
ammonium sulfate, and purified by phenyl-Sepharose chromatogra-ruses exit cells via the same MVB pathway. In support of
phy (Amersham Pharmacia; pure AIP11–716 eluted at80 mM ammo-this idea, two human class E proteins (AIP1 and TSG101)
nium sulfate from a linear gradient of 1–0 M over 200 ml). Massbind directly to structural proteins from two different
spectrometry confirmed the identity of AIP1–716 (minus the N-terminalviruses (HIV-1 p6/TSG101/AIP1 and EIAV p9/AIP1) and
methionine). Yields were typically 20 mg AIP1–716 per liter culture.
link them directly into the MVB pathway. Moreover, a The expression and purification of human VPS4 proteins will be
dominant-negative VPS4A protein that induces a class described elsewhere (A.S., F.G. Whitby, W.I.S., and C.P. Hill, unpub-
lished data).E phenotype blocks the release of viruses that bud via all
Human Class E Proteins and HIV Budding
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Protein Interactions PTAP-GFP have been described (Garrus et al., 2001; Hermida-Mat-
sumoto and Resh, 2000)Biosensor Measurements
Binding affinities of pure Tsg101 UEV domains to immobilized GST-
AIP1714–723 (AREPSAPSIP) were quantified using a Biacore biosensor Immunofluorescence
COS-7 cells growing on glass cover slips in 60 mm dishes (in DMEM/(20	C in 20 mM sodium phosphate, 150 mM NaCl, 0.01% P20, 50
g/mL BSA, [pH 7.2]) (Garrus et al., 2001). 10% FBS) were transfected with 2 g plasmid DNA and 12 l Gene-
Jammer (Stratagene) as per manufacturer’s instructions. Twenty-GST Affinity Cochromatography
GST-CHMP fusion proteins used in affinity cochromatography (pull- four hr posttransfection, cells were fixed in 3.7% formaldehyde/PBS
and permeabilized in 0.1% Triton X-100/PBS/1%BSA. Cells weredown) assays (Figure 3) were expressed from pGEX vectors in
BL21(DE3) E. coli, prebound to glutathione agarose (Amersham- incubated with either rabbit anti-M6PR (1:200, from Peter Lobel) or
mouse anti-Lamp-2 (1:200, Developmental Hybridoma) at 23	C forPharmacia), and tested for binding to AIP11–716, VPS4A, or VPS4B
following manufacturer’s instructions. 60 min. Samples were washed and incubated with goat antirabbit
or antimouse Alexa 488-conjugated antibodies (1:750, MolecularImmunoprecipitations
293T cells (10 cm plate) were cotransfected (Lipofectamine 2000, Probes). FLAG-tagged CHMP4 proteins were detected using Alexa
488-or Alexa 594-congugated anti-FLAG (1:750, Sigma M2). ImagesInvitrogen) with 6 g pcAIP1-Myc expression vector (see below)
and 6 g CHMP4B-FLAG or control vector (modified from were collected as single wavelengths on an Olympus FVX confocal
fluorescent microscope with a 60 Pianapo objective (1.4 NA oil),pcDNA3.1). Cells were harvested (24 hr), lysed for 30 min on ice in
20 mM Tris·HCl [pH 7.4], 150 mM NaCl, 0.5% NP-40, with 2 M using Fluoview 2.0.39 software. 0.5 m thick Z sections or merged
Z stacks are shown. Reslicing and three-dimensional representationpepstatin, 1 mM PMSF, 10 g/mL leupeptin, 5 g/mL aprotinin, and
clarified by centrifugation (16,000 g for 30 min). Lysate (1 mg total of Z sections were created with Volocity imaging software (Impro-
vision).protein) was incubated (3 hr, 4	C) with 1 g of anti-FLAG antibody
(M2, Sigma) and antimouse IgG rabbit antibody (Zymed) conjugated
to Protein A Sepharose (Amersham Bioscience). Unbound proteins HIV Protein Expression in 293T Cells
For Western blots of Gag expression, infectivity assays and EM,were removed by washing with lysis buffer, and bound proteins
analyzed by Western blotting with anti-FLAG (1:5000; Sigma M2) or 293T cells in 6-well plates were transfected with 9 l Lipofectamine
2000 (Invitrogen) per 2 g HIV-R9 
 1 g other expression vectorsanti-Myc antibodies (clone 9E10, 1:1000, Covance Inc.).
per well as described (Garrus et al., 2001).
Antibody Production
Gag Western Blots and Viral Replication AssaysAntibodies to recombinant AIP11–716 (sera UT324
UT325), CHMP2A
Cytoplasmic proteins and sucrose-pelleted virions (Figure 5) were(UT318), VPS4A (UT289), and VPS4B (UT292) were raised in New
harvested 36 hr after transfection, resolved by 12% SDS-PAGE,Zealand White Rabbits (Covance Inc.). Affinity columns were pre-
blotted, and detected by ECL as described (von Schwedler et al.,pared with 1 mg of purified GST fusion proteins coupled to NHS-
1998). Primary antibodies were rabbit anti-CA #40 at 1:2000 andactivated crosslinked agarose (1 ml HiTrapTM NHS-activated HP
rabbit anti-MA at 1:20,000. HIV infectious titers were assayed bycolumn, Amersham Biosciences) following manufacturer’s instruc-
MAGI assays in P4 cells (von Schwedler et al., 1998).tions. Antiserum (1 mL) was applied to PBS-equilibrated columns,
incubated (1 hr, 23	C), and washed with 10 ml PBS. Bound antibody
Electron Microscopywas eluted in 50 mM glycine, 150 mM NaCl, [pH 2.5], neutralized
For EM studies, transfected 293T cells were fixed, stained, andimmediately by addition of 0.2 M Tris·HCl, [pH 8.0], concentrated
embedded in Spurr’s plastic 48 hr after transfection (Garrus et al.,using Vivaspin 0.5 ml concentrators (Vivascience) and dialyzed
2001), and EM images were obtained at magnifications of 5000–against PBS. Anti-CHMP1A was a gift from Dan Stauffer.
150,000.
Detection of Proteins Incorporated into HIV-1 Particles
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